Print and Electronic Media
CFI is continuing the fight against COVID-19. Below is a collection of written articles that showcase CFI's efforts.
Star Tribune- 01/23/2022
Dr. Marc Jenkins is interviewed in the Star Tribune story about the debate over natural immunity and vaccine mandates. "Natural immunity can be very potent but it can also be not so potent, and that depends on the level of the initial infection," Jenkins said. "Because of that, and in the absence of a robust antibody testing program, it's best to try and get people to very high levels of protection through vaccination."
Star Tribune - 11/18/2021
Dr. Marc Jenkins, director of the Center for Immunology, spoke with Jeremy Olson from the Star Tribune about SARS-CoV-2 immunology and the importance of boosters. Dr. Jenkins says that the best strategy, for now, is for everyone to get boosters to increase protection in everyone rather than risk leaving some people vulnerable to infection.
Star Tribune - 10/1/2021
Dr. Marc Jenkins, from the Department of Microbiology and Immunology, published research that backs vaccines for those who had a previous SARS-CoV-2 infection. The study, published in Cell Reports, shows that people with prior infections who received the two-dose mRNA vaccination had five times more memory B cells — a better immune response — compared to those who received the same vaccination but were never previously infected.
Dr. Marc Jenkins describes mRNA as "one of the important worker bees of the body." Learn how new mRNA vaccines utilize naturally occurring processes in our bodies to protect ourselves against COVID 19. Read the Star Tribune article: ow.ly/2tfm50F0x2h or view the entire Star Tribune Editorial Board's #OurBestShot series, which enlists Minnesota health and community leaders to deliver timely trustworthy answers. Link here
What's Next in COVID Vaccine? Research at the University of Minnesota looks for new ways to fight the virus
The March/April 2021 issue of Minnesota Medicine Magazine interviewed Drs. Susan Kline and Marc Jenkins about the development of vaccines and subsequent distribution and what the future will look like as COVID research carries on. Dr. Jenkins talks about the current vaccine projects that several labs within CFI are currently working on to protect against COVID and any future forms of the virus. Read the entire article written by Linda Picone here
So, what’s your titer?
That question, still strange sounding, may soon become important as vaccines bring about the endgame for COVID-19. Dr. Marc Jenkins talks with Joe Carlson from the Star Tribune on December 7, 2020 about a newly developed blood test made by Imanis Life Sciences in Rochester, MN. The test will give consumers a quantitative measurement of their neutralizing antibody titers that will definitively provide the amount of virus-killing antibodies in their systems . to read the full article.
“Everyone’s impatient and I can see why...But there’s no easy path to this knowledge” about immunity. Dr. Marc Jenkins talks with Matthew Perrone, AP news and published in The Washington Post on September 7, 2020 about the ongoing studies of vaccine production, antibody testing and the standard nasal swab tests that diagnose active infections. Click here to read the full article.
Jen Christensen, from CNN.com interviews several immunologists including CFI's Dave Masopust on the multi-functionality of CoV-2 immunity and also highlights the work coming out from CFI alum, immunologist Marion Pepper's work at the University of Washington which finds that the immune response is not a "one-trick pony." Instead it is like a "Swiss Army knife that has a lot of different tools" for fighting the novel coronavirus. Read the article here.
Covid-19 vaccine: why do we develop permanent immunity with some diseases and not with others? (and the big question mark about the coronavirus)
The question now is what will happen to SARS-CoV-2: will permanent immunity to covid-19, the disease that causes the new coronavirus, be possible? To find the answer, we must observe what happens inside our body. Here's what two immunologists - one in the United States, one in Europe - say about the issue and why the vaccine is key to achieving immunity. Read what Dr. Marc Jenkins tells Lucía Blasco from BBC News Mundo in an article from 8-17-2020.
Combining a PCR test and an antibody test helps categorize those tested into four categories—information that will equip the state to confidently send Minnesotans back to work. The antibody test, known as an ELISA (enzyme-linked immunosorbent assay), developed rapidly from the lab bench to the clinic with the help of a unique group of collaborators—Amy Karger, MD, PhD, Marc Jenkins, PhD, and Fang Li, PhD. Combined with the University’s diagnostic (PCR) test, labs will be able to categorize those tested into four categories—information that will equip the state to confidently send Minnesotans back to work. "Together, they are informative if you do them both in the same person,” said Amy Karger, MD, PhD, an assistant professor in the Department of Laboratory Medicine and Pathology. She leads the team at the University’s Advanced Research and Diagnostic Laboratory (ARDL) that brought the test from a research setting into clinical use. Click here
The lab of Marc Jenkins, Regents and Distinguished McKnight University Professor at the Medical School and director of the Center for Immunology, has developed a COVID-19 antibody test that will be available first to frontline health care workers in M Health Fairview’s Bethesda Hospital. Fang Li, an associate professor in the College of Veterinary Medicine, was among the first to publish a peer-reviewed article in Nature detailing the underlying structure of COVID-19. On March 21, Li provided protein material to the Jenkins Lab, and work began. Click here
The University of Minnesota and Mayo Clinic are now offering antibody tests to find out who has recovered from COVID-19. The antibody test which was developed by CFI Investigators under Dr. Marc Jenkins and the Mayo Clinic Clinical Microbiology Laboratory has been successful in identifying antibodies that produce an immune response to the COVID-19 virus. Full Star Tribune article from April 14, 2020 click here
CFI director Dr. Marc Jenkins explains how the University of Minnesota and Mayo Clinic are close to unveiling antibody tests that can determine if people have already been infected by the coronavirus that causes COVID-19 and are no longer threats to get or spread the infection. To read the entire Star Tribune article from March 30, 2020 click here.
The Star Tribune's Christopher Snowbeck and CFI's Director Marc Jenkins talk about "a whole new approach to vaccines" using viral RNA instead of the way current vaccines are produced using a weakened or killed form of a virus to stimulate an immune system response that produces antibodies. To read the entire Star Tribune article click here.